<DOC>
	<DOCNO>NCT01330342</DOCNO>
	<brief_summary>The study 's chief objective observe evolution cellular ( term expression transmembrane transporter transcriptional regulator ) viral resistance ( term development mutation HIV genome may confer resistance future treatment HIV ) HIV-infected patient lymphoma .</brief_summary>
	<brief_title>Evolution Cellular Viral Resistance HIV-infected Patients With Lymphoma</brief_title>
	<detailed_description>The study team take two three tube blood three occasion course chemotherapy . The total amount blood require research project 64mL ( approximately 4 tablespoon ) . This allow well understanding change take place blood HIV virus . It hop provide new insight may aid understand treatment HIV patient lymphoma .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>The ability understand sign write informed consent form , prior participation screen procedure must willing comply study requirement . Documented HIV1 infection . Diagnosis lymphoma ( exclusion five subject control ) . On cART start cART part clinical routine care initiation chemotherapy . Receiving antituberculosis treatment .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>